Skip to main content

IR CONTACT

Carlo Tanzi, Ph.D.
Seres Therapeutics, Inc.
Head of Investor Relations and Corporate Communications
Phone: 617-203-3467
E-mail: ctanzi@serestherapeutics.com

Back to top